Glutathione cycle in stable chronic obstructive pulmonary disease

Cell Biochemistry and Function

Volumn 28, Issue 6, 2010, Pages 448-453

  Biljak, Vanja Radišić ^a   Rumora, Lada ^b   Čepelak, Ivana ^b   Pancirov, Dolores ^c   Popović Grle, Sanja ^d   Sorić, Jasna ^b   Grubišić, Tihana Žanić ^b  

^a University of Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Dr Ivo Pedi i General Hospital   (Croatia)

^d UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Chronic obstructive pulmonary disease; Glutathione peroxidase; Glutathione reductase; Oxidative stress; Smoking; Total glutathione

Indexed keywords

GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CATALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOKING;

AGED; CASE-CONTROL STUDIES; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 77956824403     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1675     Document Type: Article

References (37)

1. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 50-60. (Pubitemid 40562963)
2. MacNeeW. Oxidative stress and lung inflammation in airways disease. (Review) Eur J Pharmacol 2001; 429: 195-207.
3. Mak JCW. Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance. Int J Tuberc Lung Dis 2008; 12: 115-127.
4. Bowler RP, Barnes PJ, Crapo JD. The role of oxidative stress in chronic obstructive pulmonary disease. COPD 2004; 1: 255-277.
5. Jackson AA, Gibson NR, Lu Y, Jahoor F. Synthesis of erythrocyte glutathione in healthy adults consuming the safe amount of dietary protein. Am J Clin Nutr 2004; 80: 101-107.
6. Arthur JR. The glutathione peroxidases. Cell Mol Life Sci 2000; 57: 1825-1835.
7. Dickinson DA, Forman HJ. Glutathione in defense and signalling. Lessons from a small thiol. Ann NY Acad Sci 2002; 973: 488-504.
8. Rahman I, MacNee W. Lung glutathione and oxidative stress: Implications in cigarette smoke-induced airway disease. Am J Physiol Lung Cell Mol Physiol 1999; 277: 1067-1088.
9. Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation (Review). Eur Respir J 2000; 16: 534-554.
10. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
11. Baker MA, Cerniglia GJ, Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 1990; 190: 360-365.
12. Paglia DE, Valentine WN. Studies on the quantitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
13. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985; 113: 484-490.
14. Solak ZA, Kabaroǧlu C, Çok G, et al. Effect of different levels of cigarette smoking on lipid peroxidation, glutathione enzymes and paraoxonase 1 activity in healthy people. Clin Exp Med 2005; 5: 99-105.
15. Joppa P, Petrášová D, Stančák B, Dorková Z, Tkáčová R. Oxidative stress in patients with COPD and pulmonary hypertension. Wien Klin Wochenschr 2007; 119: 428-434.
16. Matskevich GN, Korotkina RN, Devlikanova Ash, Vishnevskii AA, Karelin AA. The study of the antioxidant enzymes in erythrocytes in lung disease. Patol Fiziol Eksp Ter 2003; 2: 23-25.
17. Nadeem A, Raj HG, Chhabra SK. Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease. Inflammation 2005; 29: 23-32.
18. Santos MC, Oliveira AL, Viegas-Crespo AM, et al. Systemic markers of the redox balance in chronic obstructive pulmonary disease. Biomarkers 2004; 9: 461-469.
19. Vibhuti A, Arif E, Deepak D, Singh B, Qadar Pasha MA. Correlation of oxidative status with BMI and lung function in COPD. Clin Biochem 2007; 40: 958-963.
20. Kluchová Z, Petrášová D, Joppa P, Dorková Z, Tkáčová R. The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol Res 2007; 56: 51-56.
21. Low FM, Hampton MB, Winterbourn CC. Peroxiredoxin 2 and peroxide metabolism in the erythrocyte. Antioxid Redox Signal 2008; 10: 1621-1629.
22. Raes M, Michiels C, Remacle J. Comparative study of the enzymatic defense systems against oxygen-derived free radicals: The key role of glutathione peroxidase. Free Radic Biol Med 1987; 3: 3-7.
23. Brown KM, Pickard K, Nicol F, Beckett GJ, Duthie GG, Arthur JR. Effects of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphocytes, granulocytes, platelets and erythrocytes. Clin Sci 2000; 98: 593-599.
24. Januel C, El Hentati FZ, Carreras M, et al. Phospholipid-hydroperoxide glutathione peroxidase (GPx-4) localization in resting platelets, and compartmental change during platelet activation. Biochim Biophys Acta 2006; 1761: 1228-1234.
25. Toppo S, Vanin S, Bosello V, Tosatto SCE. Evolutionary and structural insights into the multifaceted glutathione peroxidase (Gpx) superfamily. Antioxid Redox Signal 2008; 10: 1501-1514.
26. Brigelius-Flohé R. Glutathione peroxidases and redox-regulated transcription factors. Biol Chem 2006; 387: 1329-1335.
27. Pigeolet E, Corbisier P, Houbion A, et al. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Dev 1990; 51: 283-297.
28. Shapiro BL, Smith QT, Warick WJ. Serum glutathione reductase and cystic fibrosis. Pediatr Res 1975; 9: 885-888.
29. Grant CM, Collinson LP, Roe JH, Dawes IW. Yeast glutathione reductase is required for protection against oxidative stress and is a target gene for yAP-1 transcriptional regulation. Mol Microbiol 1996; 21: 171-179.
30. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007; 47: 89-116.
31. Harvey CJ, Thimmulappa RK, Singh A, et al. Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic Biol Med 2009; 46: 443-453.
32. Gipp JJ, Wartman MB, Mulcahy RT. Promoter analysis of the human glutathione reductase gene. Society of Toxicology 40th Annual Meeting 2001; 60: 210.
33. Andersson A, Ankerst J, Lindgren A, Larsson K, Hultberg B. Hyperhomocysteinemia and changed plasma thiol redox status in chronic obstructive pulmonary disease. Clin Chem Lab Med 2001; 39: 229-2331.
34. Peltoniemi MJ, Rytilä PH, Harju TH, et al. Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease. Respir Res 2006; 7: 133.
35. van der Toorn M, Smit-de Vries MP, Slebos D-J, et al. Cigarette smoke ireversibly modifies glutathione in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2007; 293: L1156-L1162.
36. Reddy S, Finkelstein EI,Wong PS, Phung A, Cross CE, van der Vliet A. Identification of glutathione modifications by cigarette smoke. Free Radic Biol Med 2002; 33: 1490-1498.
37. Ochs-Balcom HM, Grant BJ, Muti P, et al. Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD. Eur J Clin Nutr 2006; 60: 991-999.